Brainstorm Cell Therapeutics | BCLI - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Biogen USD 1.96B 69.6M 2026-03
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Mesoblast USD 82.31M 26.16M 2025-12